The Relationship between Ozone and Human Blood in the Course of a Well-Controlled, Mild, and Transitory Oxidative Eustress

• Published in: Antioxidants Vol. 10; no. 12; p. 1946
• Main Authors: Tricarico, Gerardo, Travagli, Valter
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04-12-2021; MDPI
• Subjects: Blood; Fatty acids; lipid ozonation products; Lipid peroxidation; Lipids; Oxidation; oxidative stress; oxidative therapies; Ozone; ozone therapy; Plasma; reactive oxidative species; Reactive oxygen species; Topical application; Toxicity; immunomodulation; ozone therapy; oxidative therapies; reactive oxidative species; blood; lipid ozonation products; oxidative stress
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox10121946

In the last twenty years there has been a proliferation of articles on the therapeutic use of ozone. As it is well-known, the term ozone therapy is very broad. It ranges from either systemic or loco-regional administration of unstable gaseous oxygen/ozone mixtures to the topical application of stable ozonated derivatives. Anyway, in relation to the absence of specific receptors and the extreme reactivity with the biological liquids with which it comes into contact, gaseous ozone cannot be classified as either a drug or a pro-drug. When the gaseous ozone impacts a biological matrix, both reactive oxygen species (ROS) and lipid oxidation products (LOPs) are formed. They represent the effector molecules responsible for modulating the therapeutic activity in the body. Apart from the merits of the action mechanisms resulting from the use of ozone, this article seeks to validate the practice of ozone therapy as an adjuvant treatment in full compliance with the physiology of the whole organism.